-
The combination of a CBC and a BMP can predict death.
-
Obstructive sleep apnea (OSA) is inextricably linked with adverse cardiovascular events including stroke, MI, hypertension (HTN), and arrhythmia.
-
A new opioid analgesic with a dual mechanism of action has been released for market by PriCara, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
-
The ECG in the tracing above was obtained from a 68-year-old man who presented with a history of fatigue for the past 3 weeks, but no chest pain. No history of coronary artery disease, and no prior tracings were available for comparison. How would you interpret his ECG in view of this clinical history?
-
Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
Aspirin reduces the risk for myocardial infarction in men ages 45-79 and for stroke in women ages 55-79; however, its use must be balanced against the increased risk of serious bleeding events in each individual patient.
-
Group visits of diabetic patients have the power to foster lifestyle change, improve the control of diabetes and related cardiovascular risk factors, and lower health care costs.
-
Bromocriptine, a dopamine receptor agonist initially approved in 1978 as Parlodel®, has been approved for the treating type 2 diabetes mellitus. The drug is marketed as a quick release formulation by VeroScience LLC as Cycloset™.
-
CT colonography is a screening tool that appears to be reasonably good at identifying colorectal cancer in asymptomatic patients at increased risk for colorectal cancer when compared to colonoscopy. Increased risk is defined as those with a family history of advanced neoplasia in first-degree relatives, personal history of colorectal adenomas, or positive results from fecal occult blood tests (FOBTs).
-
When using an NSAID, a physician must weigh the anticipated therapeutic benefits and assess the potential risks from both the cardiovascular and gastrointestinal perspectives, and the final therapeutic decision should be individualized.
